Health Care Costs and Opioid Use Associated With High-impact Chronic Spinal Pain in the United States
- PMID: 31373999
- PMCID: PMC6758926
- DOI: 10.1097/BRS.0000000000003033
Health Care Costs and Opioid Use Associated With High-impact Chronic Spinal Pain in the United States
Abstract
Study design: A descriptive analysis of secondary data.
Objective: The aim of this study was to estimate health care costs and opioid use for those with high-impact chronic spinal (back and neck) pain.
Summary of background data: The US National Pain Strategy introduced a focus on high-impact chronic pain-that is, chronic pain associated with work, social, and self-care restrictions. Chronic neck and low-back pain are common, costly, and associated with long-term opioid use. Although chronic pain is not homogenous, most estimates of its costs are averages that ignore severity (impact).
Methods: We used 2003 to 2015 Medical Expenditures Panel Survey (MEPS) data to identify individuals with chronic spinal pain, their health care expenditures, and use of opioids. We developed prediction models to identify those with high- versus moderate- and low-impact chronic spinal pain based on the variables available in MEPS.
Results: We found that overall and spine-related health care costs, and the use and dosage of opioids increased significantly with chronic pain impact levels. Overall and spine-related annual per person health care costs for those with high-impact chronic pain ($14,661 SE: $814; and $5979 SE: $471, respectively) were more than double that of those with low-impact, but still clinically significant, chronic pain ($6371 SE: $557; and $2300 SE: $328). Those with high-impact chronic spinal pain also use spine-related opioids at a rate almost four times that of those with low-impact pain (48.4% vs. 12.4%), and on average use over five times the morphine equivalent daily dose (MEDD) in mg (15.3 SE: 1.4 vs. 2.7 SE: 0.6). Opioid use and dosing increased significantly across years, but the increase in inflation-adjusted health care costs was not statistically significant.
Conclusion: Although most studies of chronic spinal pain do not differentiate participants by the impact of their chronic pain, these estimates highlight the importance of identifying chronic pain levels and focusing on those with high-impact chronic pain.
Level of evidence: 3.
Similar articles
-
Health costs of women with chronic overlapping pain conditions by opioid and complementary and integrative health use.Health Serv Res. 2021 Dec;56(6):1233-1244. doi: 10.1111/1475-6773.13875. Epub 2021 Sep 12. Health Serv Res. 2021. PMID: 34453324 Free PMC article.
-
Pharmacoeconomic Analysis of Pain Medications Used to Treat Adult Patients with Chronic Back Pain in the United States.J Pain Palliat Care Pharmacother. 2016 Dec;30(4):300-307. doi: 10.1080/15360288.2016.1231735. Epub 2016 Oct 17. J Pain Palliat Care Pharmacother. 2016. PMID: 27749151
-
Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use.Spine (Phila Pa 1976). 2007 Sep 1;32(19):2127-32. doi: 10.1097/BRS.0b013e318145a731. Spine (Phila Pa 1976). 2007. PMID: 17762815
-
Spinal Cord Stimulation vs Conventional Therapies for the Treatment of Chronic Low Back and Leg Pain: A Systematic Review of Health Care Resource Utilization and Outcomes in the Last Decade.Pain Med. 2019 Dec 1;20(12):2479-2494. doi: 10.1093/pm/pnz185. Pain Med. 2019. PMID: 31498396
-
Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.Postgrad Med. 2011 Nov;123(6):132-9. doi: 10.3810/pgm.2011.11.2503. Postgrad Med. 2011. PMID: 22104462 Review.
Cited by
-
Classifying chronic pain using multidimensional pain-agnostic symptom assessments and clustering analysis.Sci Adv. 2021 Sep 10;7(37):eabj0320. doi: 10.1126/sciadv.abj0320. Epub 2021 Sep 8. Sci Adv. 2021. PMID: 34516888 Free PMC article.
-
Real-World Evidence in Prescription Medication Use Among U.S. Adults with Neck Pain.Pain Ther. 2020 Dec;9(2):637-655. doi: 10.1007/s40122-020-00193-1. Epub 2020 Sep 17. Pain Ther. 2020. PMID: 32940899 Free PMC article.
-
Effectiveness of Spinal Manipulation and Biopsychosocial Self-Management compared to Medical Care for Low Back Pain: A Randomized Trial Study Protocol.Res Sq [Preprint]. 2023 May 3:rs.3.rs-2865633. doi: 10.21203/rs.3.rs-2865633/v1. Res Sq. 2023. Update in: BMC Musculoskelet Disord. 2023 May 25;24(1):415. doi: 10.1186/s12891-023-06549-w. PMID: 37205428 Free PMC article. Updated. Preprint.
-
Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT-study protocol of the PIANISSIMO study.PLoS One. 2024 Aug 12;19(8):e0302842. doi: 10.1371/journal.pone.0302842. eCollection 2024. PLoS One. 2024. PMID: 39133680 Free PMC article.
-
Understanding the etiopathogenesis of lumbar intervertebral disc herniation: From clinical evidence to basic scientific research.JOR Spine. 2023 Oct 18;7(1):e1289. doi: 10.1002/jsp2.1289. eCollection 2024 Mar. JOR Spine. 2023. PMID: 38222810 Free PMC article. Review.
References
-
- Office of the Assistant Secretary for Health. National Pain Strategy Washington, DC: US Department of Health and Human Services; Accessed November 9, 2016.
-
- Von Korff M, Scher AI, Helmick C, et al. United States National Pain Strategy for Population Research: Concepts, Definitions, and Pilot Data. J Pain 2016;17(10):1068–1080. - PubMed
-
- Deyo RA, Dworkin SF, Amtmann D, et al. Report of the NIH Task Force on research standards for chronic low back pain. Pain Med 2014;15(8):1249–1267. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials